Harae Dx

Next generation cancer diagnostics — bridging healthcare IT and diagnostics.

Pleasanton, United States · Founded 2021 · $350K raised

Employees
1–10
Founded
2021
Business Model
B2B
Total Funding
$350K
Last Round
$350K Pre-SeedApr 2021
Rounds
1

About

Harae Dx is developing the world's first low-cost, portable, fully automated AI-based cancer detection system. The company's proprietary, patented technology platform is designed to detect cancer biomarkers with unprecedented speed and efficiency, delivering complete automated functional results in approximately 30 minutes without sending specimens to third-party laboratories. The system targets breast cancer detection and other cancer biomarkers, achieving 85% sensitivity and 91% specificity. Harae Dx is headquartered in Pleasanton, California.

Summary

Harae Dx is an Artificial Intelligence company based in Pleasanton, United States, founded in 2021. It has raised $350K in total across 1 round, most recently a $350K Pre-Seed round in Apr 2021. Investors include SOSV, Fusion Fund and HAX Growth.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Pre-seedPre-SeedApr 2021
$350K

Investors

Similar Companies